Tissue samples, tissue arrays, cells, microorganisms, probes and services for your research.
Payment methods we support:
✭ Invoice / Purchase Order
✭ Credit card
2019-nCoV is a novel pathogen emerged at the end of 2019. On February 11, 2020, the World Health Organization (WHO) officially named the disease caused by 2019-nCoV as Coronavirus Disease 2019 (COVID-19). Patients with COVID-19 pneumonia presented with the symptoms of fever, chest tightness, and fatigue. A small number of the patients have severe acute respiratory syndrome, renal failure and even death. So far, there is still no effective treatment to combat this infection.
In addition, it has been reported that ACE2 receptors serve as binding sites for COVID-19 in the lungs. Creative Bioarray offers you several animal models to help you with pathogenesis studies, development of vaccines, and evaluating therapeutics for COVID-19. All animal testing associated with COVID-19 research will be performed in the Biosafety Level 3 (BSL3) facility.
Available Animal Models
With the emergence of COVID-19, Creative Bioarray is ready for the challenge and to provide our customers with the best solutions so that they can complete their project smoothly. All employees of Creative Bioarray are ready to fight against COVID-19.
Animal Testing Services of Anti-SARS-CoV-2 Drug Development
Customized Research Design Service
Please contact us for more details and let us know your research interests. Creative Bioarray offer animal models that are well-suited for testing drug candidates in early antiviral therapeutic discovery, giving your confidence about your results. Customized service is available to meet your every scientific need.
Quotation and Ordering
If you have any special needs or questions regarding our services, please feel free to contact us at 631-626-9181 or email@example.com. We look forward to cooperating with you in the future.